Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.04 | 11752688 14514962 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.75 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.16 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.50 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.50 | 14692618 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.83 | 3712494 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.57 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.70 | 21441931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.08 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.06 | 10982225 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
18.14 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
18.14 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
18.14 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.74 | 15885639 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.41 | 18445737 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.24 | 11289319 1440618 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.18 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.01 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.85 | 15746008 |
OMIM:612394 |
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS |
marker/mechanism |
|
| |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.92 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.94 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
2.01 | 17020986 11325840 17388661 12006526 18234424 16978400 15093573 18323546 15136595 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.01 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.01 | 17369602 15939500 19526202 15136595 15668708 15634643 18382427 18628466 16115903 16595493 15993339 16096432 15994142 16264153 15692762 16322301 15567936 16935488 17983394 17426702 16826403 18695136 18234424 11325840 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.01 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.03 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.91 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
9.10 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
9.10 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
9.10 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
9.10 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
9.10 | 17876044 18059187 16234567 16023760 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
5.08 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
11.20 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
11.20 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
11.20 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.67 | 6189445 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.44 | 18850075 16120746 18670907 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.62 | 17351982 17928571 15792986 16455267 17329180 17382496 16651473 16952015 16731534 17007740 16109756 15476868 15811867 16612575 15505089 16278810 16364871 17974986 16269455 16242529 17131338 17519947 18627295 17308081 17924179 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.98 | 17334414 16243910 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.66 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.70 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
11.70 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.70 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.29 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
14.00 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
14.00 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
14.00 | 16919318 15861022 17681005 17333356 16105132 17110522 11677210 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.15 | 16354765 8697196 15340226 15668235 12621046 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18259882 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.18 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 20055451 15322242 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.19 | 18551238 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
5.20 | 16614059 11948286 12913760 10700343 12388444 12161096 16413132 18295254 15276878 18483878 16989017 17979934 18372110 18710439 18093676 16651033 15643279 17010015 10498854 18433785 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.97 | 8970840 18759878 11298694 8156756 11906362 12868966 14531868 2524372 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.64 | 3621924 2952479 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.18 | 15331540 11751995 10990075 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.26 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
12.42 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
12.42 | 18289764 16192314 11289319 9022650 9653073 8291058 18648102 9328219 6482804 1440618 18692083 6679447 7440962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
12.42 | 2444490 19416960 19370779 18071297 19923254 11421492 16485898 16781746 15619225 14986274 16081117 11739529 16177239 12540782 12153990 10915739 16393943 14725611 12392966 17906064 10774834 11461765 19085960 16227642 17562736 11834606 15968718 12958197 12594235 14550746 18713872 12705907 19164858 11529661 16109766 17522070 10663392 19739265 19420014 11287661 11743745 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
12.42 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
12.42 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.32 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.46 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.46 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.55 | 18367378 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.51 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.12 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.35 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.54 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.15 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.37 | 18037988 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.39 | 11006010 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.14 | 3581430 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.12 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
13.90 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
13.90 | 17967931 19551842 19004024 18296743 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
13.90 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.63 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.24 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.78 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
15.78 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
15.78 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
15.78 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.89 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.41 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.43 | 17150277 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.71 | 11389073 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.19 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.81 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
5.21 | 16376943 11014644 15172196 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.62 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.40 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.58 | 16707910 16495754 18674790 18006777 16144979 14766674 12587719 16879835 16244371 17875725 16330681 16244372 17888722 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.42 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.04 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.62 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.47 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.48 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.75 | 14986274 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.67 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.07 | 15340226 12621046 16120746 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
8.12 | 16135485 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
8.12 | 15147373 18501091 17606976 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.26 | 16959395 15340226 8697196 18606429 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.81 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.73 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.76 | 21332399 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
4.11 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.10 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.10 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.98 | 16569931 16945680 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.55 | 16076520 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.61 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
7.18 | 7193160 16517039 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
7.18 | 17937319 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
5.14 | 20412841 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.14 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
3.19 | 18457598 11836018 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.24 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.48 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.66 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
10.49 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
10.49 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
10.49 | 16775033 15699352 15369732 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.29 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
13.06 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
13.06 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
13.06 | 12371664 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
3.55 | 10602166 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.37 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.55 | 17802794 17296974 17008537 18172266 18587576 17658394 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.19 | 10373061 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
5.16 | 11830472 10052129 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.95 | 18296743 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.28 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.47 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.47 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.66 | 12969438 12587719 19460945 16611625 19784758 11587558 19014921 16610002 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.37 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.53 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.53 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
14.82 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
14.82 | 598648 3712494 6587162 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
14.82 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.82 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.43 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.43 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
8.21 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
8.21 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.75 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
9.39 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
9.39 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.74 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.11 | 15458769 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.30 | 16827129 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
11.43 | 19513568 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
11.43 | 16388313 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.11 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.01 | 16801185 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.64 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.98 | 17415656 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.00 | 15857846 19429709 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.13 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.05 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
6.01 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
6.01 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
3.19 | 18854779 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.94 | 16636307 16899518 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.66 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
9.71 | 18481113 19348381 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.71 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.37 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
3.00 | 6679447 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
7.44 | 15176712 8761367 16115947 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
7.44 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.99 | 18514411 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
5.08 | 12837982 8761367 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.47 | 8291058 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.31 | 19632207 16723640 18674790 11836018 17217161 20132043 21332399 20518802 18457598 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.33 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
9.33 | 6482804 4026338 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.90 | 16517039 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.24 | 3988306 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.23 | 15930896 |
MESH:D010146 |
Pain |
|
Acetaminophen |
7.24 | 16870215 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
7.24 | 12161096 18093676 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
3.23 | 11332152 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.84 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.66 | 7296757 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.47 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.69 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.37 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.37 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.72 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.35 | 12371664 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.87 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.38 | 11118676 11896295 11399792 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
3.60 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.60 | 16729912 16868541 18437689 15897917 16888761 15749863 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.51 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.27 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.33 | 16636934 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.40 | 17922066 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.00 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.48 | 3692021 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.12 | 18313854 17203757 17710206 16767912 15675481 15625365 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.40 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.98 | 17846226 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.97 | 16636934 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.62 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
5.89 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.89 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.74 | 15625365 16767912 17203757 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.16 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.71 | 16517039 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.25 | 12837982 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.77 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.28 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.12 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.62 | 6587162 6582329 7505956 3712494 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
7.62 | 16010429 17909728 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
12.39 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.39 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
12.39 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
12.39 | 17653716 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.51 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.12 | 10982225 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.46 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.20 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.81 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.68 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.40 | 17334414 16364871 17678736 17638931 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.47 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.86 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.66 | 17120751 |